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Histopathological Image Analysis: A Review
Metin N. Gurcan, Senior Member, IEEE, Laura E. Boucheron, Member, IEEE, Ali Can,
Anant Madabhushi, Senior Member, IEEE, Nasir M. Rajpoot, Member, IEEE, and Bulent Yener, Senior Member, IEEE
Methodological Review
Abstract—Over the past decade, dramatic increases in computa-
tional power and improvement in image analysis algorithms have
allowed the development of powerful computer-assisted analytical
approaches to radiological data. With the recent advent of whole
slide digital scanners, tissue histopathology slides can now be
digitized and stored in digital image form. Consequently, digitized
tissue histopathology has now become amenable to the application
of computerized image analysis and machine learning techniques.
Analogous to the role of computer-assisted diagnosis (CAD)
algorithms in medical imaging to complement the opinion of a
radiologist, CAD algorithms have begun to be developed for dis-
ease detection, diagnosis, and prognosis prediction to complement
the opinion of the pathologist. In this paper, we review the recent
state of the art CAD technology for digitized histopathology. This
paper also briefly describes the development and application of
novel image analysis technology for a few specific histopathology
related problems being pursued in the United States and Europe.
Index Terms—Computer-aided diagnosis, computer-assisted in-
terpretation, digital pathology, histopathology, image analysis, mi-
croscopy analysis.
I. INTRODUCTION AND MOTIVATION
T HE widespread use of computer-assisted diagnosis(CAD) can be traced back to the emergence of digital
mammography in the early 1990s [1]. Recently, CAD has
become a part of routine clinical detection of breast cancer
on mammograms at many screening sites and hospitals [2] in
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the United States. In fact, CAD has become one of the major
research subjects in medical imaging and diagnostic radiology.
Given recent advances in high-throughput tissue bank and
archiving of digitized histological studies, it is now possible
to use histological tissue patterns with computer-aided image
analysis to facilitate disease classification. There is also a
pressing need for CAD to relieve the workload on pathologists
by sieving out obviously benign areas, so that the pathologist
can focus on the more difficult-to-diagnose suspicious cases.
For example, approximately 80% of the 1 million prostate
biopsies performed in the U.S. every year are benign; this
suggests that prostate pathologists are spending 80% of their
time sieving through benign tissue.
Researchers in both the image analysis and pathology fields
have recognized the importance of quantitative analysis of
pathology images. Since most current pathology diagnosis is
based on the subjective (but educated) opinion of pathologists,
there is clearly a need for quantitative image-based assessment
of digital pathology slides. This quantitative analysis of digital
pathology is important not only from a diagnostic perspective,
but also in order to understand the underlying reasons for a
specific diagnosis being rendered (e.g., specific chromatin
texture in the cancerous nuclei which may indicate certain
genetic abnormalities). In addition, quantitative characteriza-
tion of pathology imagery is important not only for clinical
applications (e.g., to reduce/eliminate inter- and intra-observer
variations in diagnosis) but also for research applications
(e.g., to understand the biological mechanisms of the disease
process).
A large focus of pathological image analysis has been on
the automated analysis of cytology imagery. Since cytology im-
agery often results from the least invasive biopsies (e.g., the cer-
vical Pap smear), they are some of the most commonly encoun-
tered imagery for both disease screening and biopsy purposes.
Additionally, the characteristics of cytology imagery, namely
the presence of isolated cells and cell clusters in the images and
the absence of more complicated structures such as glands make
it easier to analyze these specimens compared to histopathology.
For example, the segmentation of individual cells or nuclei is a
relatively easier process in such imagery since most of the cells
are inherently separated from each other.
Histopathology slides, on the other hand, provide a more
comprehensive view of disease and its effect on tissues,
since the preparation process preserves the underlying tissue
architecture. As such, some disease characteristics, e.g., lym-
phocytic infiltration of cancer, may be deduced only from
1937-3333/$26.00 © 2009 IEEE
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a histopathology image. Additionally, the diagnosis from a
histopathology image remains the “gold standard” in diag-
nosing considerable number of diseases including almost all
types of cancer [3]. The additional structure in these images,
while providing a wealth of information, also presents a new set
of challenges from an automated image analysis perspective. It
is expected that the proper leverage of this spatial information
will allow for more specific characterizations of the imagery
from a diagnostic perspective.
The analysis of histopathology imagery has generally fol-
lowed directly from techniques used to analyze cytology im-
agery. In particular, certain characteristics of nuclei are hall-
marks of cancerous conditions. Thus, quantitative metrics for
cancerous nuclei were developed to appropriately encompass
the general observations of the experienced pathologist, and
were tested on cytology imagery. These same metrics can also
be applied to histopathological imagery, provided histological
structures such as cell nuclei, glands, and lymphocytes have
been adequately segmented (a complication due to the com-
plex structure of histopathological imagery). The analysis of
the spatial structure of histopathology imagery can be traced
back to the works of Wiend et al. [4], Bartels [5] and Hamilton
[6] but has largely been overlooked perhaps due to the lack of
computational resources and the relatively high cost of digital
imaging equipment for pathology. However, spatial analysis of
histopathology imagery has recently become the backbone of
most automated histopathology image analysis techniques. De-
spite the progress made in this area thus far, this is still a large
area of open research due to the variety of imaging methods and
disease-specific characteristics.
A. Need for Quantitative Image Analysis for Disease Grading
Currently, histopathological tissue analysis by a pathologist
represents the only definitive method (a) for confirmation of
presence or absence of disease and (b) disease grading, or the
measurement of disease progression. The need for quantitative
image analysis in the context of one specific disease (prostate
cancer) is described below. Similar conclusions hold for quan-
titative analysis of other disease imagery.
Higher Gleason scores are given to prostate cancers, which
are more aggressive, and the grading scheme is used to predict
cancer prognosis and help guide therapy. The Gleason grading
system is based solely on architectural patterns; cytological
features are not evaluated. The standard schematic diagram
created by Gleason and his group (see Fig. 1) separated archi-
tectural features into 1 of 5 histological patterns of decreasing
differentiation, pattern 1 being most differentiated and pattern 5
being least differentiated. The second unique feature of Gleason
grading is that grade is not based on the highest (least differen-
tiated) pattern within the tumor. Recently several researchers
have reported discrepancies with the Gleason grading system
for grading prostate cancer histopathology. Many researchers
have found grading errors (both under- and over-grading) in
prostate cancer studies [7]–[11]. Similar issues with cancer
grading have been reported for other diseases such as breast
cancer [12].
Fig. 1. Schema showing different cancer grades prevalent in prostate cancer.
In light of the above, Luthringer et al. [13] have discussed
the need for changes to be made to Gleason grading system. In
late 2005, the International Society of Urologic Pathologists in
conjunction with the World Health Organization (WHO) made
a series of recommendations for modifications to the Gleason
grading system, including reporting any higher grade cancer, no
matter how small quantitatively.
Luthringer et al. [13] have also suggested the need for
re-evaluation of original biopsy material by a highly experi-
enced pathologist which could help guide patient management.
Stamey et al. [14] discussed need for developing methods to
accurately measure cancer volume and better estimate prostate
cancer to better predict progression of cancer. King et al. [8]
has similarly called for developing a methodology to help
reduce pathologic interpretation bias which would likely result
in significantly improved accuracy of prostate cancer Gleason
grading.
B. Differences in CAD Approaches Between
Radiology and Histopathology
While CAD is now being used in radiology in conjunction
with a wide range of body regions and a variety of imaging
modalities, the preponderant question has been: can CAD
enable disease detection? Note that this question, as opposed
to more diagnostic questions, is motivated by the inherent
limitation in spatial resolution of radiological data. For in-
stance, in mammography, CAD methods have been developed
to automatically identify or classify mammographic lesions. In
histopathology, on the other hand, simply identifying presence
or absence of cancer or even the precise spatial extent of cancer
may not hold as much interest as more sophisticated questions
such as: what is the grade of cancer? Further, at the histological
(microscopic) scale one can begin to distinguish between dif-
ferent histological subtypes of cancer, which is quite impossible
(or at the very least difficult) at the coarser radiological scale.
It is fair to say that since CAD in histopathology is still
evolving, the questions that researchers have started to ask of
pathology data are not as well articulated as some of the prob-
lems being investigated in radiology. A possible reason for this
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is that image analysis scientists are still trying to come to terms
with the enormous density of data that histopathology holds
compared to radiology. For instance, the largest radiological
datasets obtained on a routine basis are high-resolution chest
CT scans comprising approximately 512 512 512 spatial
elements or million voxels. A single core of prostate
biopsy tissue digitized at 40 resolution is approximately
15 000 15 000 elements or million pixels. To put this
in context, a single prostate biopsy procedure can comprise
anywhere between 12 and 20 biopsy samples or approximately
2.5–4 billion pixels of data generated per patient study. Due
to their relatively large size and the content, these images fre-
quently need to be processed in a multiresolution framework.
Also, while radiological CAD systems mostly deal with gray-
scale images, histological CAD systems often need to process
color images. Furthermore, with the recent advent of multispec-
tral and hyperspectral imaging, each pixel in a histopathology
section could potentially be associated with several hundred
sub-bands and wavelengths.
These fundamental differences in radiology and
histopathology data have resulted in specialized CAD schemes
for histopathology. While several similar reviews have been
published for CAD in medical imaging and diagnostic radi-
ology [15]–[23], to the best of our knowledge no related review
has been undertaken for digitized histopathology imagery. A
survey for CAD histopathology is particularly relevant given
that the approaches and questions being asked of histological
data are different from radiological data. The motivation
of this paper is to present a comprehensive review of the
state-of-the-art CAD methods and the techniques employed for
automated image analysis of digitized histopathology imagery.
C. Organization of This Paper
We have organized this paper to follow the general image
analysis procedures for histopathology imagery. These analysis
procedures are generally applicable to all imaging modalities.
In Section II, we describe digital pathology imaging modalities
including immunofluorescence and spectral imaging and ex-
plain the difference between cytopathology and histopathology.
In Section III, image preprocessing steps such as color nor-
malization and tissue auto-fluorescence compensation are re-
viewed. In Section IV, we discuss recent advances in detec-
tion and segmentation in histopathological images. Section V is
dedicated to feature extraction and selection at different levels,
with real-world examples. In Section VI, we review classifi-
cation and sub-cellular quantification. Finally, in Section VII
we discuss some of the potential issues that image analysis of
histopathology could be used to address in the future and pos-
sible directions for the field in general.
While there are a large number of applicable methods
for preprocessing (Section III), detection and segmentation
(Section IV), feature extraction and selection (Section V), and
classification and sub-cellular quantification (Section VI), we
will present here only some common examples. We refer the
interested reader to the references contained within the various
sections for further reading.
II. DIGITAL PATHOLOGY IMAGING MODALITIES
A. Histopathology and Cytopathology
Histopathology is the study of signs of disease using the mi-
croscopic examination of a biopsy or surgical specimen that
is processed and fixed onto glass slides. To visualize different
components of the tissue under a microscope, the sections are
dyed with one or more stains. The aim of staining is to reveal
cellular components; counter-stains are used to provide contrast.
Hematoxylin-Eosin (H&E) staining has been used by patholo-
gists for over a hundred years. Hematoxylin stains cell nuclei
blue, while Eosin stains cytoplasm and connective tissue pink.
Due to the long history of H&E, well-established methods, and
a tremendous amount of data and publications, there is a strong
belief among many pathologists that H&E will continue to be
the common practice over the next 50 years [24].
Cytology, on the other hand, is related to the study of cells in
terms of structure, function and chemistry. Resulting from the
least invasive biopsies (e.g., the cervical Pap smear), cytology
imagery is the most commonly encountered for both disease
screening and biopsy purposes. Additionally, the characteristics
of cytology imagery, namely the presence of isolated cells and
cell clusters in the images, and the absence of more complicated
structures such as glands make it easier to analyze these speci-
mens compared to histopathology.
B. Immuno-Fluorecence Imaging and Multiple
Imaging Modalities
Recently, immuno-fluorescent labeling-based image analysis
algorithms have been presented to quantify localization of pro-
teins in tissue [25]–[27]. Commonly used molecular markers
are based on chromogenic dyes (such as DAB), or fluorescent
dyes (such as Cy dyes or Alexa dyes). Fluorescent dyes have the
advantage of multiplexing the dyes to acquire images of mul-
tiple proteins. A general overview of molecular labeling, high
throughput imaging, and pattern recognition techniques is pre-
sented by Price et al. [28].
With current imaging techniques, it is not possible to simul-
taneously image H&E dyes and immuno-fluorescent molecular
biomarkers due to fluorescent characteristics of the H&E
dyes, and due to chemical interactions of H&E dyes with the
fluorescently labeled antibodies. Recently, methods have been
developed to facilitate sequential imaging and registration
techniques that enable different modalities presented digitally
from the same histological tissue section. Additionally, se-
quential imaging and registration enables imaging of multiple
immuno-fluorescent stains acquired in multiple steps rather
than conventional simultaneous multiplexing techniques. This
allows an order of magnitude increase in the number of molec-
ular markers to be imaged for the same tissue section. These
techniques make it possible to explore unexamined relation-
ships between morphology, sub-cellular spatial distribution
of proteins, and protein-protein interactions. An example of
these techniques is shown in Fig. 2. For brightfield images,
hematoxylin stains the nuclei blue [Fig. 2(a)], and for fluores-
cent images DAPI can be used to stain nuclei [blue channel in
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Fig. 2. (a) H&E image of a breast tumor tissue. Fluorescently labeled markers superimposed as green color on the H&E image, (b)  -catenin, (c) pan-keratin,
and (d) smooth muscle -actin, markers.
Fig. 2(a)]. The first nuclei image is set as the reference image
and each of the subsequent nuclei images are registered to the
reference. Once the transformation parameters are estimated,
then all the channels at a sequential step are mapped onto
the reference coordinate system. Fig. 2(b)–(d) shows super-
imposed b-catenin, pan-keratin, and smooth muscle a-actin
markers superimposed on the H&E with green pseudo-color
[29]. Another recently developed sequential imaging method
known as MELC [30] has the ability to produce images of
the same specimen with up to 100 proteins by utilizing the
photo-bleaching characteristics of the fluorescent dyes.
One of the major problems with such “multichannel”
imaging methods is the registration of the multiplexed images,
since physical displacements can easily occur during sequen-
tial imaging of the same specimen. In [29], the authors used
mutual information-based error metrics to register the nuclei
images from sequential staining steps. While the fluorescent
images include dedicated nuclei channels (such as DAPI), the
nuclei images from the H&E images can be computed using
decomposition techniques [31], [32], or using simple ratio or
differencing methods that utilize the fact that blue wavelengths
are absorbed less than green and red channels by the hema-
toxylin dye.
C. Spectroscopic Imaging Modalities for Histopathology
In recent years, several spectral data acquisition methods
have been employed to aid the diagnosis process with additional
information about the biochemical makeup of cells and other
tissue constituents. Generally, computerized histopathology
image analysis takes as its input a three-channel (red, green,
and blue or RGB) color image captured by digital imaging
equipment (normally a CCD camera) and attempts to emulate
the manual analysis and/or provide additional quantitative
information to aid in the diagnosis. While analysis of ordinary
color images has been shown to be useful, one of the major
drawbacks is that only three color channels of the light spec-
trum are used, potentially limiting the amount of information
required for characterizing different kinds of tissue constituents.
On the other hand, recently proposed immuno-histochemistry
(IHC) methods are not sufficiently well developed for their use
in quantitative pathology [33].
Spectral methods offer a relatively inexpensive way of pro-
viding a deeper insight into tissue composition. Most of these
methods can be categorized into three broad classes: point spec-
troscopy, spectral imaging, and spectroscopic imaging. Point
spectroscopy is a well-established area of study whereby, in the
context of histopathology, the chemical composition of a tissue
sample is ascertained with the help of the spectrum emitted or
absorbed at a specific point on the biopsy. Point spectroscopy
methods can employ both visible light and beyond. Spectral
imaging, also known as multispectral or hyperspectral imaging,
measures intensity of light from the entire optical field after
exciting the sample with visible light of varying wavelengths.
Spectroscopic imaging combines the strengths of both of the
above two methods, building spatial imaging of the human
tissue in a multitude of wavelength regimes.
1) Point Spectroscopy: Vibrational spectroscopy is the most
widely researched point spectroscopy method for characteriza-
tion of normal and diseased tissue. It measures molecular vibra-
tions, induced by incident light, corresponding to the chemical
makeup at the molecular level in two different ways: absorption
of electromagnetic radiation or frequency shifts between inci-
dent and scattered light—the so-called Raman scattering effect.
In case of infrared (IR) absorption spectroscopy, the sample is
irradiated with a mid-IR beam and the transmitted light is exam-
ined for absorption of energy. The absorption spectrum, a plot
of absorption versus different wavelengths, can reveal the bio-
chemical makeup of the molecules. IR spectroscopy has been
used to analyze tissue constituents at a molecular level for al-
most 60 years [34], [35]. Indeed, IR spectra was investigated
for characterization of normal and neoplastic tissue as far back
as 1952 by Woernley [36], who also showed that the absorption
at certain frequencies can be correlated with the concentrations
of nucleic acids in tissues. Recent advances in machine learning
and pattern recognition algorithms and the development of the
IR spectroscopic imaging modality have renewed interest in this
technique for studying the biochemical makeup of healthy and
diseased tissue.
In Raman spectroscopy, the sample is illuminated with a
monochromatic visible or near-IR (NIR) light from a laser
source and frequency shifts in the scattered light are measured.
The Raman spectrum is a plot of intensity of the scattered
photon versus shifts in its frequency, often measured in terms
of wave numbers in cm . NIR-Raman spectroscopy is often
used as an alternative to IR spectroscopy since NIR light has
higher energy than mid-IR light and can penetrate much farther
into the sample.
Fourier-transform (FT) spectroscopy, known as FT-IR when
IR light is used, allows a faster acquisition of the IR spectra
by using an interferometer followed by the Fourier transform
(FT). FT-IR spectroscopy is the most commonly used form of
IR spectroscopy.
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2) Spectral Imaging: Spectral imaging is carried out by
building an image cube with slices corresponding to images of
the same scene obtained by incident light at differing wave-
lengths. This technique is referred to as multispectral (MS) or
hyperspectral (HS) imaging depending on the number of
spectral bands, individual slices of the image cube in the spec-
tral direction (generally with for MS and for
HS).
3) Spectroscopic Imaging: Spectroscopic imaging is similar
to spectral imaging in that a volumetric cube is obtained with
a spectrum per pixel in the optical field. The main difference is
that spectroscopic imaging builds the image cube by dividing
the image scene into a uniform Cartesian grid, raster scanning
the scene according to the grid, and collecting point spectra for
each of the grid points.
Fernandez et al. [33] have proposed an IR spectroscopic
imaging method based on a Michelson interferometer and
all-reflecting microscope equipped with a 16-element linear
array detector with a narrow aperture size of 6.25 6.25
m. A massive 1641-dimensional point spectrum was obtained
for each pixel spanning a spectral range of 4000–720 cm
at an effective spectral resolution of 2 cm and at a spatial
resolution of 6.25 m. Tissue sections were also stained with
H&E and imaged with a digital light microscope for manual
histopathology analysis.
While most of the above methods are generally invasive for
internal body organs, magnetic resonance spectroscopy (MRS)
is a completely noninvasive way of probing the biochemical
makeup of tissue. By this virtue, it is a particularly attractive
prospect for the imaging of brain tumors, along with magnetic
resonance (MR) imaging which has become a mainstay in the
diagnosis of suspicious brain lesions [37]. The main principle
behind MRS imaging is the chemical shift process, the process
whereby different metabolites in the tissue respond at different
resonating frequencies, with the chemical shift often measured
in parts per million (ppm). One particular advantage of MRS
is that it can be tuned to specific nuclei in the tissue; with hy-
drogen ( , also known as proton) being the most commonly
studied one. Studies have shown clear differences between
MRS spectra of brain tumors and normal brain [38].
4) Spectral Analysis for Histopathology: In IR spec-
troscopy, McIntosh et al. [39] investigated the use of infrared
spectroscopy for the characterization of in vitro basal cell carci-
noma (BCC) specimens, exploiting the fact that mid-IR light is
absorbed by a variety of skin components. Point spectroscopy
was performed using an IR spectrometer and an aperture of
20 m 20 m from carefully selected regions containing
only one type of skin lesion. Their analysis of the normalized
spectra employing linear discriminant analysis (LDA) iden-
tified absorption bands that arise mainly from CH2 and CH3
absorptions in dermal spectra that are similar to those seen
in samples rich in protein and collagen in particular. H&E
staining for standard histological examination was carried out
after the spectra had been obtained. In a more recent paper,
McIntosh et al. [40] utilized LDA to analyze the near-IR (NIR)
absorption spectrum for noninvasive, in vivo characterization of
skin neoplasms. Their rationale for using NIR light was that the
mid-IR light could be completely absorbed by samples greater
than 10–15 m in thickness, therefore limiting the utility of
mid-IR spectroscopy to in vitro analysis.
In Raman spectroscopy, Frank et al. [41] examined Raman
spectra from breast and observed that visible laser excita-
tion could be used to reveal Raman features for lipids and
carotenoids. Huang et al. [42] explored the use of a rapid acqui-
sition NIR Raman spectroscopy system for in vitro diagnosis
of lung cancer. Student’s -test was performed to discriminate
between normal and malignant bronchial tissues using the ratio
of Raman intensity at two specific wavelengths. Chowdary et
al. [43] showed that the Raman spectra could be useful for
discriminating between normal and diseased breast tissues,
although a simple principle component analysis (PCA) of
spectra was employed for discrimination purposes. Analyzing
the Raman spectra of malignant breast tissues, they concluded
that malignant tissues had an excess of lipids and proteins.
Robichaux-Viehoever et al. [44] investigated the use of NIR
Raman spectra for the detection of cervical dysplasia and
achieved high correlation between the results of their spectral
analysis and the histopathology diagnosis.
Recently, Wang et al. [45] have shown that FT-IR spec-
troscopy can be effectively used for detecting premalignant
(dysplastic) mucosa and leads to better inter-observer agree-
ment, in terms of the -statistic. Oliveira et al. [46] have
explored a setup involving a fixed-wavelength (1064 nm) laser
line as an excitation source and FT-Raman for generating the
spectra. Spectral analysis using PCA and Mahalanobis distance
were used to detect dysplastic and malignant oral lesions.
Their results using LDA showed effective separation of spectra
of benign lesions from those of premalignant and malignant
lesions.
Over the years, MS and HS imaging have demonstrated an
enormous potential in remote-sensing applications, leading
many researchers to expect promise about their usefulness in
histopathology [47]. This promise has been demonstrated by
and [48] in their work on the diagnosis of colon adenocar-
cinoma. However, two recent studies [49], [50] have found
that the additional spectral information does not significantly
improve the classification results. This may be due to the fact
that most MS and HS imaging methods employ the visible part
of light spectrum which may not be very useful in terms of
highlighting important biochemical characteristics, as opposed
to the near-IR or mid-IR spectrum. The number of stains
present in the sample, as well as the characteristics of the stains
themselves will also directly affect the performance of MS and
HS image analysis methods.
In MRS, several studies, such as [51], can be found in
the literature that report high correlation between automatic
grading of in vivo tumors and their corresponding post-opera-
tive histopathology findings. However, MRS spectral analysis
has traditionally been limited to rather simplistic ratio tests.
Tiwari et al. [52] recently proposed an unsupervised spectral
clustering-based algorithm for diagnosis of prostate cancer
from the MRS spectra, reporting higher specificity compared
to the popular -score scheme, routinely used for the analysis
of MRS data.
Spectral analysis using different modalities discussed above
has demonstrated its potential for diagnosis and grading of
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cancer in tissue samples. However, as outlined above, most of
the proposed algorithms in the literature make use of linear
sub-space projection methods (PCA, LDA, etc.) for analysis
of the spectral data despite the fact that spectral signatures of
different types of tissue in the high-dimensional space may
not be linearly separable. Furthermore, a few challenges are
limiting the success of such methods in the realm of optical
diagnostics. These include, but are not limited to, storage
and transmission, registration, processing and analysis of large
amounts of data generated by spectral data acquisition methods.
The problem is further compounded when gathering spectral
imaging data for whole slides. However, the availability of
powerful computational resources at increasingly low prices
and recent advances in image analysis have meant that more
sophisticated methods can now be applied for analyzing large
amounts of spectral data.
III. IMAGE PREPROCESSING: COLOR AND ILLUMINATION
NORMALIZATION
A. Color Normalization
One of the first steps essential for both fluorescent and bright
field microscopy image analysis is color and illumination nor-
malization. This process reduces the differences in tissue sam-
ples due to variation in staining and scanning conditions. The
illumination can be corrected either using calibration targets or
estimating the illumination pattern from a series of images by
fitting polynomial surfaces [29]. Another approach is to match
the histograms of the images. Software that corrects for spec-
tral and spatial illumination variations is becoming a standard
package provided by most bright field manufacturers. This is
an essential step for algorithms that heavily depend on color
space computations. Yang and Foran [53] presented a robust
color-based segmentation algorithm for histological structures
that used image gradients estimated in the LUV color space to
deal with issues of stain variability. In the next section, we give
detailed description of correcting another artifact, tissue autoflu-
orescence, in fluorescent images.
B. Compensating for Tissue Auto-Fluorescence
Tissue auto-fluorescence (AF) is a fundamental problem in
microscopy applications, particularly in retrospective studies
that use formalin fixed paraffin embedded tissue sections. AF
reduces the signal detection sensitivity, and in some cases even
causes failure in the detection of fluorescent biomarker signals.
In [29], a two-step technique was used to remove the AF from
fluorescent microscopy images. Rather than acquiring images
of all the dyes at once using a set of optimum filter cubes
tuned to specific dyes, the acquisition is done in two steps.
In the first step, tissue is stained with only the low AF dyes
(e.g., ultraviolet or infrared), and images are acquired using
all the filter cubes. Images of these cubes, except the low AF
dyes, represent the tissue AF at their specific spectra. In the
second step, all the remaining dyes are added, and images of
all the cubes are acquired again. Then the first set of images is
aligned with the second set using a transformation estimated by
registering the low-AF images that are common in both steps.
The first step before any AF removal is the correction of the
excitation light pattern. The observed image, , can be
modeled as a product of the excitation pattern, and the emis-
sion pattern. While the emission pattern captures the tissue de-
pendent fluorescent staining, the excitation pattern captures the
excitation light. In the logarithm domain, the multiplicative re-
lation can be transformed into a linear form. The excitation pat-
tern can be estimated using the mean of the brightest set of pixels
from an ordered set of images
(3.1)
where denote the ordered pixels (
), and represents
the set of brightest pixels. Assuming that a certain percentage
of the image occupies stained tissue (nonzero backgound), is
set to an integer to represent this percentage (10% in our exper-
iments). This approximation holds if a large number of images
are used in the averaging process. However, a large percentage
of pixels are already excluded to eliminate the nontissue pixels
in the images. To overcome the limited sampling size, the log
of the excitation pattern estimated in (3.1) can be approximated
with polynomials. The surface generated by the polynomial
coefficients are then used to correct individual images [54].
After the images are corrected for their light excitation pat-
tern, the images between the two sequential steps are aligned.
From the two common images, one being the reference image
from the first step, , and the second being from the sub-
sequent step, , a rigid transformation is obtained,
such that the image similarity measure, between and
is maximized
(3.2)
Due to its robustness in registering multimodality images, a mu-
tual information-based image similarity measure is used to deal
with tissue loss and folding. Additional robustness is achieved
by incorporating the mutual information estimation in a mul-
tiresolution framework [55].
Once is estimated, all the channels are transformed with
this transformation to represent all the images in both acquisi-
tions in the same coordinate system. Then the first set of im-
ages is subtracted from the second set of images. To achieve
the highest dynamic range, the first set of AF images can be ac-
quired in longer exposure times than the second set of AF-dye
mixture images. Fig. 3 shows the acquisition of the Cy3 channel
before and after the tissue is stained with Cy3 dye directly con-
jugated with Estrogen Receptor (ER). The tissue is also stained
with a low AF ultraviolet nuclear stain, DAPI (not shown in the
figure), which is acquired in both steps and used for aligning
the images. The AF removed image is shown in Fig. 3(c). The
arrows point to successfully removed high-AF regions, such as
red blood cells. Removing the AF using the proposed two-step
approach enables accurate image analysis and quantitation for
low abundance proteins and directly conjugated antibodies.
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Fig. 3. (a), (b) Images from the first step acquisition. (c), (d) Images from the second acquisition. (e), (f) AF-free corrected images. Cy5 dye (a), (c), (e) is directly
conjugated to Pan-Cadherin, a membrane protein. Cy3 dye (b), (d), (f) is directly conjugated to Estrogen Receptor. The arrows point to successfully removed the
high-AF regions, such as blood cells and fat.
IV. AUTOMATED DETECTION AND SEGMENTATION
OF HISTOPATHOLOGY IMAGES
One of the prerequisites to grading or diagnosis of disease
in histopathology images is often the identification of cer-
tain histological structures such as lymphocytes, cancer nu-
clei, and glands. The presence, extent, size, shape, and other
morphological appearance of these structures are important
indicators for presence or severity of disease. For instance,
the size of the glands in prostate cancer tend to reduce with
higher Gleason patterns [56]. Similarly, the presence of a
large number of lymphocytes in breast cancer histopathology
is strongly suggestive of poor disease outcome and survival
[57]. Consequently, a prerequisite to identification and classi-
fication of disease is the ability to automatically identify these
structures. These approaches can either be global, in which
they attempt to simultaneously segment all the structures in
the image scene or local approaches which target specific
structures.
Another motivation for detecting and segmenting histological
structures has to do with the need for counting of objects, gener-
ally cells or cell nuclei. Cell counts can have diagnostic signifi-
cance for some cancerous conditions. Bibbo et al. [58] reported
1.1%–4.7% error in cell counts compared to manual counts for
Feulgen-stained prostate specimens. Belien et al. [59] found
19%–42% error in counting mitoses in Feulgen-stained breast
tissue sections. In immunohistochemically stained bone marrow
biopsies, Markiewicz et al. [60] reported 2.8%–10.0% differ-
ence in counts between manual and automatic methods, while
Kim et al. [61] found a correlation of 0.98 between manual
and automatic counts of immunostained slides of meningiomas.
Sont et al. [62] found a correlation of 0.98 between automated
and semi-automated methods for inflammatory cell counts in
immunostained bronchial tissue.
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Fig. 4. (a) Original DCIS image with corresponding (b) likelihood scene obtained via a Bayesian classifier driven by color and texture. (c) Thresholded version
of likelihood scene (95% confidence). (d) The final nuclear segmentation obtained by integrating the Bayesian classifier with the template matching scheme.
A. Local, Structural Segmentation
1) Nuclear Segmentation: Numerous works have been
conducted [63]–[65] on segmentation of various structures
in breast histopathology images using methodologies such as
thresholding, fuzzy c-means clustering, and adaptive thresh-
olding [65]. Thresholding tends to work only on uniform
images and does not produce consistent results if there is con-
siderable variability within image sets. Watershed algorithms
tend to pose the same problem [64] due to variability in image
sets. Active contours are widely used in image segmentation;
however, contours enclosing multiple overlapping objects pose
a major limitation. In addition, inclusion of other irrelevant
objects from the background further complicates the possibility
of obtaining a viable segmentation.
The pixel-level analysis of unstained prostate slides
by Fourier transform infrared spectroscopy resulted in
94%–100% accuracy in the pixel-level classification of ten
histologic classes as reported by Fernandez et al. in [66]. The
pixel-level classification of nuclear material by Boucheron
et al. [67] resulted in performances (equal tradeoff between
detection and false alarm rates) of 88%–90% for H&E stained
breast tissue. The use of automated methods for pixel-level
analysis is perhaps more common for immunostained or
fluorescently stained specimens. Singh et al. [68] reported
98% accuracy in the detection of positive and negative
prostate nuclei immunostained for androgen receptor protein
expression. Analysis of cytokeratin-stained lymph node
sections yielded 95% detection of stained cells as reported
by Weaver et al. in [69]. However, these studies focus only
on finding nuclei on a pixel level.
In H&E stained imagery of astrocytomas and bladder tissue,
Glotsos et al. [70] reported that 94% of nuclei were correctly
delineated. Latson et al. found 25% poorly segmented nuclei,
4.5%–16.7% clumped nuclei, and 0.4%–1.5% missed nuclei
in H&E stained breast biopsies. Fluorescently stained imagery
of cervical and prostate carcinomas allowed for 91%–96% ac-
curacy in cell segmentation by Wahlby et al. [71], where the
accuracy here is calculated based on manual cell counts (i.e.,
not taking into account the accuracy of the actual nuclear de-
lineation). Korde et al. used image intensity thresholding to
segment nuclei in the bladder and in skin tissue [72]. Gurcan
et al. leveraged gray level morphology followed by hysteresis
thresholding to achieve cell nuclei segmentation in digitized
H&E stained slides [73], [74]. Other algorithms have been pro-
posed using more complex techniques, such an active contour
scheme for pap-stained cervical cell images by Bamford and
Lovell [75] and a fuzzy logic engine proposed by Begelman et
al. [76] for prostate tissue that uses both color- and shape-based
constraints.
In [63] and [77], nuclear segmentation from breast and
prostate cancer histopathology was achieved by integrating
a Bayesian classifier driven by image color and image tex-
ture and a shape-based template matching algorithm (Fig. 4).
Fig. 4(a) shows a Ductal carcinoma in situ (DCIS) study with a
number of nuclei closely packed together. The likelihood image
representing the probability of each pixel corresponding to a
nuclear region is shown in Fig. 4(b). Note that several nuclei
lie adjacent to each other and hence template matching is used
to extricate the individual nuclei. Fig. 4(c) shows the result of
thresholding the Bayesian likelihood scene (95% confidence
level). Template matching is then done at every location in
Fig. 4(c). Only those image locations where correspondence
between the binary segmentation [Fig. 4(c)] and the template
was found are shown as bright. The final nuclear boundary
detection (green dots) is displayed in Fig. 4(d).
2) Gland Segmentation: In a recently presented scheme for
extracting glandular boundaries from histopathology scenes
[63], the algorithm consists of three distinct components: In
the first stage, a Bayesian classifier is trained based on color
and textural information to automatically identify nuclei, cy-
toplasm, and lumen regions in the scene. Following low-level
Bayesian classification, structural constraints are incorporated
to constrain the segmentation by using image information
regarding the specific order of arrangement of glandular
structures (central lumen, surrounding cytoplasm, and nuclear
periphery) in order to reduce the number of false positive gland
regions. Finally, a shape-based segmentation method in the
form of level sets [78] is initialized within candidate lumen
regions as determined from the Bayesian classifier. Hence,
the level set surface evolution is controlled by the Bayesian
probability scene derived via use of the low-level image in-
formation. The level set evolution is stopped at the interface
between lumen and cytoplasm and, thus, a segmentation of
the inner gland boundary is obtained. A second level set is
then initialized within the cytoplasm area and used to capture
the outer gland margin. Once the possible gland lumens are
found, boundary segmentation is performed using level-sets.
A boundary evolving in time and in the 2-D space defined
by the grid of pixels is represented by the zero level set
of a level set function , where
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Fig. 5. Results of the automatic segmentation algorithm (blue contours: lumen
boundary, black contours: inner boundary of the nuclei of the epithelial cells
surrounding the gland). Shown from left to right are example images of benign
epithelium, intermediate-, and high-grade cancer.
and are 2-D Cartesian coordinates of . The evolution of
is then described by a level-set formulation adopted from [78]
(4.1)
where the function defines the speed of the evolution. The
curve evolution is driven by the nuclei likelihood image. The
initial contour is initialized automatically using
the detected lumen area from the candidate gland regions. The
curve is evolved outward from the detected lumen regions in
the combined nuclei likelihood image to avoid noise and allow
smoother evolution relative to the original image. The intensities
of the nuclei likelihood image form the stopping gradient. The
algorithm is run until the difference in the contours in two con-
secutive iterations is below an empirically determined threshold.
During training, size distributions similar to those used to calcu-
late object likelihood are created using the final contours. These
nuclear boundary based distributions are used to remove regions
that are too large to be true glands. Finally, the lumen and nu-
clear boundaries extracted from true gland regions are passed on
to the next step for feature extraction. Sample results from the
automated gland segmentation algorithm are shown in Fig. 5.
The lumen boundaries are displayed in a solid blue contour and
the interior nuclear boundaries are displayed as dashed black
lines. Results of our gland segmentation algorithm are shown
for sample images from benign epithelium, intermediate, and
high-grade prostate cancer (from left to right).
B. Global Scene Segmentation Approaches
In [26], a unified segmentation algorithm for sub-cel-
lular compartmentalization was presented. Quantitation of
biomarkers at sub-cellular resolution requires segmentation
of sub-cellular compartments such as nuclei, membranes, and
cytoplasm. While different segmentation algorithms can be
used for each of the sub-cellular compartments, an alternative
is to use the same algorithm in different modes. The algorithm
in [26] captured a set of bright pixels sharing a common shape
distribution. The algorithm used a set of three features, one is
the fluorescent emission intensity, and the other two are based
on curvature descriptors that are computed from the eigenvalues
of the Hessian matrix.
For an image, , the eigenvalues ( )
of the Hessian matrix encode the curvature information of
the image, and provide useful cues for detecting ridge-like
membrane structures, or blob-like nuclei structures. However,
the eigenvalues are dependent on image brightness. The fol-
lowing two curvature-based features are independent of image
brightness:
(4.2)
(4.3)
and referred to as shape index, and normalized-curvature index,
respectively. This is essentially the same as defining the eigen-
values in a polar coordinate system. This transformation also
results in bounded features, , and
.
The estimation process starts with the expected distributions
of the shape index for the structures to be segmented. For ex-
ample, for bright membrane and vessel like structures the shape
index is close to , because the smaller eigenvalue is nega-
tive and the larger eigenvalue approaches to zero. On the other
hand, for the blob-like nuclei structures, the shape index is close
to , because both eigenvalues are negative and close in
value. For both structures, positive values indicate a pixel being
more like a background. These constraints are used to compute
the initial foreground and background sets for membrane and
nuclei structures. An initial segmentation based on the shape
index and the normalized-curvature index separates the image
pixels into three subsets: background, foreground, and indeter-
minate. The indeterminate subset comprises all the pixels that
are not included in the background or foreground subsets. From
these subsets, the background and foreground intensity distri-
butions, as well as the intensity log-likelihood functions are es-
timated. The algorithm keeps iterating by using two out of the
three features at a time to estimate the distribution of the feature
that is left out. In the final step, these log-likelihood functions
are combined to determine the overall likelihood function. A
probability map that represents the probability of a pixel being
a foreground is calculated.
Cytoplasm can be detected either by using a specific cy-
toplasmic marker, or can be detected using computational
methods using the fact that the cytoplasmic areas are between
nuclear and membrane areas. For most cancer tissue types,
it is very important to differentiate the epithelial tissue from
the stromal and connective tissue, so that for IHC studies the
expression levels of most markers in the epithelial regions
can be quantified. Computational methods that use the high
connectivity of membrane meshes can be used to differentiate
the epithelial regions. For the sample images, any connected
component larger than 800 pixels is accepted as a part of the
epithelial mask. The nuclei set is then separated into epithelial
nuclei and stromal nuclei using the epithelial mask.
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SUMMARY OF OBJECT-LEVEL FEATURES USED IN HISTOPATHOLOGY IMAGE ANALYSIS
EMLDA is an image segmentation method, which uses the
Fisher–Rao criterion as the kernel of the expectation maximiza-
tion (EM) algorithm [79]. Typically, the EM-algorithm is used
to estimate the parameters of some parameterized distributions,
such as the popular Gaussian mixture models, and assign labels
to data in an iterative way. Instead, the EMLDA algorithm uses
the linear discriminant analysis (LDA), a supervised classifica-
tion technique, as the kernel of EM-algorithm and iteratively
group data points projected to a reduced dimensional feature
space in such a way that the separability across all classes is
maximized. In [62], the authors successfully applied this ap-
proach in the context of histopathological image analysis to
achieve the segmentation of digitized H&E stained whole-slide
tissue samples.
V. FEATURE EXTRACTION
Research on useful features for disease classification has
often been inspired by visual attributes defined by clinicians
as particularly important for disease grading and diagnosis.
The vast majority of these features are nuclear features and
many have been established as useful in analysis of both cy-
topathology and histopathology imagery. Other features that
assume discriminatory importance include the margin and
boundary appearance of ductal, stromal, tubular, and glan-
dular structures. While there is a compilation of features for
cytopathology imagery [80], there is relatively little such work
for histopathology imagery.
Humans’ concept of the world is inherently object-based, as
opposed to the largely pixel-based representation of computer
vision. As such, human experts describe and understand images
in terms of such objects. For pathologists, diagnosis criteria are
inevitably described using terms such as “nucleus” and “cell.”
It is thus important to develop computer vision methods capable
of such object-level analysis.
A. Object Level Features
Fundamentally, object-level analysis depends greatly on
some underlying segmentation mechanism. It is the segmenta-
tion methodology that determines what constitutes an object.
Commonly, an object is defined as a connected group of pixels
satisfying some similarity criterion. The main focus is often
on the segmentation of nuclei; there exists little work that
explicitly uses features of cytoplasm and stroma, although
some researchers have hinted at the need for such features
[81], [82]. Preliminary work [83] has demonstrated the feasi-
bility of other histologic features for image classification in
H&E stained breast cancer. Madabhushi et al. [63] used cyto-
plasmic and stromal features to automatically segment glands
in prostate histopathology. Moreover, it appears that histologic
objects may not need to be perfectly segmented to be properly
classified when a list of comprehensive features is used in a
feature selection framework [83]. Classification performance
in distinguishing between different grades of prostate cancer
was found to be comparable using manual and automated
gland and nuclear segmentation [63]. These results suggest that
perfect segmentation is not necessarily a prerequisite for good
classification.
Object-level features can be categorized as belonging to one
of four categories: size and shape, radiometric and densito-
metric, texture, and chromatin-specific. While the radiometric
and densitometric, texture, and chromatin-specific features
could be considered low-level features that can be extracted
from local neighborhoods, the size and shape metrics are true
object-level metrics. A summary of object-level features is
listed in Table I; definitions for all listed features can be found
in [83]. These features were compiled from a comprehensive
literature search on cytopathology and histopathology image
analysis. In addition, various statistics measures for any of
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the vector quantities are also commonly calculated. Thus,
the mean, median, minimum, maximum, standard deviation,
skewness, and kurtosis can be calculated for all vector fea-
tures. For an RGB image, all relevant features are extracted
for each individual color channel; hence, the total number
of object-level features can easily exceed 1000 for the list of
features in Table I. It should be noted that these features are
most commonly extracted from high-resolution imagery (see
next section), but are relevant for any resolution.
An approach that semantically describes histopathology
images using model based intermediate representation (MBIR)
and incorporates low-level color texture analysis was presented
in [84]. In this approach, basic cytological components in the
image are first identified using an unsupervised clustering in
the La*b* color space. The connected components of nuclei
and cytoplasm regions were modeled using ellipses. An exten-
sive set of features can be constructed from this intermediate
representation to characterize the tissue morphology as well as
tissue topology. Using this representation, the relative amount
and spatial distribution of these cytological components can be
measured. In the application of follicular lymphoma grading,
where the spatial distribution of these regions varies consid-
erably between different histological grades, MBIR provides
a convenient way to quantify the corresponding observations.
Additionally, low-level color texture features are extracted using
the co-occurrence statistics of the color information. Due to the
staining of the tissue samples, the resulting digitized images
have considerably limited dynamic ranges in the color spectrum.
Taking this fact into account, a nonlinear color quantization
using self-organizing maps (SOM) is used to adaptively model
the color content of microscopic tissue images. The quantized
image is used to construct the co-occurrence matrix from which
low-level color texture features are extracted. By combining the
statistical features constructed from the MBIR with the low-level
color texture features, the classification performance of the
system can be improved significantly.
Fig. 6 shows some of the textural image features for dis-
criminating between benign breast epithelial tissue [77] (DCIS,
Fig. 6(a)) and DCIS (Fig. 6(d)). Fig. 6(b), (e), shows the corre-
sponding Gabor filter responses while Fig. 6(c), (f) shows the
corresponding Haralick feature images.
B. Spatially Related Features
Graphs are efficient data structures to represent spatial data
and an effective way to represent structural information by
defining a large set of topological features. Formally, a simple
graph is an undirected and unweighted graph
without self-loops, with and being the node and edge set
of graph , respectively.
Application of graph theory to other problem domains is im-
pressive. Real-world graphs of varying types and scales have
been extensively investigated in technological [85], social [86]
and biological systems [87]. In spite of their different domains,
such self-organizing structures unexpectedly exhibit common
classes of descriptive spatial (topological) features. These fea-
tures are quantified by definition of computable metrics.
Fig. 6. Supervised extraction of histological features to describe tissue appear-
ance of (a) benign epithelium, and (b) DCIS. Feature images for the two tissue
classes (benign epithelium, DCIS) corresponding to Gabor wavelet features (b),
(e) and Haralick second order features (c), (f) are shown.
Fig. 7. Bone fracture and its corresponding ECM-aware cell-graph represen-
tation. Note the presence of a link between a pair of nodes in an ECM-aware
cell-graph indicates not only topological closeness but also it implies the simi-
larity in the surrounding ECM [90].
The use of spatial-relation features for quantifying cellular
arrangement was proposed in the early 1990s [88], but did not
find application to clinical imagery until recently. Graphs have
now been constructed for modeling different tissue states and
to distinguish one state from another by computing metrics on
these graphs and classifying their values. Overall, however, the
use of spatial arrangement of histological entities (generally at
low resolutions) is relatively new, especially in comparison to
the wealth of research on nuclear features (at higher resolu-
tions) that has occurred during the same timeframe. A compi-
lation of all the spatial-relation features published in the litera-
ture is summarized in Table II. Definitions for all graph struc-
tures and features can be found in [83]. The total number of
spatial-relation features extracted is approximately 150 for all
graph structures.
Graph theoretical metrics that can be defined and computed
on a cell-graph induce a rich set of descriptive features that can
be used for tissue classification. These features provide struc-
tural information to describe the tissue organization such as: i)
the distribution of local information around a single cell cluster
(e.g., degree, clustering coefficient); ii) the distribution of global
information around a single cell cluster (e.g., eccentricity, close-
ness, between-ness); iii) the global connectivity information of
a graph (e.g., ratio of the giant connected component over the
graph size, percentage of the isolated and end data points in
the graph); iv) the properties extracted from the spectral graph
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SUMMARY OF SPATIAL-ARRANGEMENT FEATURES USED IN HISTOPATHOLOGY IMAGE ANALYSIS.
theory (e.g., spectral radius, eigen exponent, number of con-
nected components, sum of the eigenvalues in the spectrum).
Refer to Table II for a list of commonly extracted graph features.
1) 2-D Cell-Graph Construction: In cell-graph generation
as proposed in [89], there are three steps: i) color quantiza-
tion; ii) node identification; and iii) edge establishment. In
the first step, the pixels belonging to cells from those of the
others are distinguished. These steps are explained in the next
sub-sections.
Node Identification: The class information of the pixels is
translated to the node information of a cell-graph. At the end
of this step, the spatial information of the cells is translated to
their locations in the two-dimensional grid. After computing the
probabilities, these are compared against a threshold value.
Edge Establishment: This step aims to model pair-wise re-
lationships between cells by assigning an edge between them.
Cells that are in physical contact are considered to be in commu-
nication, thus edges can be established between them determin-
istically. For other node pairs, a probability function is used to
establish edges between a pair of nodes randomly. Since struc-
tural properties of different tissues (e.g., breast, bone and brain)
are quite different from each other, edge establishment must be
guided by biological hypothesis.
2) 3-D Cell-Graphs: The first step in 3-D cell-graph con-
struction is to define the distance between a pair of nodes, which
is simply the 3-D Euclidean distance between a pair of nodes.
Based on this distance definition, edges can be established be-
tween a pair of nodes. In addition to the simple spatial distance
metrics, a multidimensional distance measure can be defined
using the cell-level attributes that can be provided by sophisti-
cated image analysis and segmentation. Cell-level attributes in-
clude: , , physical contact, volume with respect to number
of pixels, peripheral (i.e., surface area), shared border as per-
centage of shared voxels relative to total, and polarity. Then
each node of the 3-D cell-graph can be represented by a vector
of -dimensions, each dimension corresponding to an attribute.
The norm can be used to compute the multidimensional dis-
tance between them. Once the notion of distance is determined,
edge functions of cell-graphs can be applied to construct 3-D
cell-graphs. The mathematical properties of cell-graphs in 3-D
can be calculated as the feature set. Although most of the fea-
tures defined on 2-D cell-graphs can be extended to the 3-D case,
their calculation is not trivial.
3) Application of Graph-Based Modeling for Different
Histopathology Related Applications:
Graph-Based Modeling of Extra Cellular Matrix: The
extra cellular matrix (ECM) is composed of a complex network
of proteins and oligosaccharides that play important roles in
cellular activities such as division, motility, adhesion, and
differentiation. Recently, a new technique was introduced for
constructing ECM-aware cell-graphs that incorporates the
ECM information surrounding the cells [90]. ECM-aware
cell-graphs aim to preserve the interaction between cells and
their surrounding ECM while modeling and classifying the
tissues. The ECM-aware cell-graphs successfully distinguish
between different types of cells that co-exist in the same tissue
sample. For example, in bone tissue samples there are usually
several cell types, including blood cells, normal cells, and
sometimes fracture cells (e.g., chondrocytes and osteoblasts)
and cancerous cells. Since these cells are functionally different
from each other, the hypothesis is that they would exhibit
different spatial organization and structural relationships in the
same tissue. This hypothesis has been validated by showing
that ECM-aware cell-graphs yield better classification results
Authorized licensed use limited to: WARWICK UNIVERSITY. Downloaded on August 12,2010 at 10:37:35 UTC from IEEE Xplore.  Restrictions apply. 
GURCAN et al.: HISTOPATHOLOGICAL IMAGE ANALYSIS: A REVIEW 159
Fig. 8. Illustrating the differences between cell-graphs for cancerous, healthy, and inflamed brain tissues. Panels (a)-(c) show brain tissue samples that are (a)
cancerous (gliomas), (b) healthy, and (c) inflamed, but noncancerous. Panels (d)-(f) show the cell-graphs corresponding to each tissue image. While the number
of cancerous and inflamed tissue samples appear to have similar numbers and distributions of cells, the structure of their resulting cell-graphs shown in (d) and (f)
are dramatically different. (Figure is taken from [91]).
for different states of bone tissues than the current state of art.
In the construction a color value is assigned to each cell (i.e.,
vertex) based on the RGB values of its surrounding ECM. This
is done by examining the neighboring pixels in each direction,
and computing a dominant color for the ECM surrounding each
cell using the RGB values of nearly neighboring pixels.
Application to Discriminating Different States of Brain
Tissue: Fig. 8 shows the cell-graphs of brain tissues exhibiting
distinctive graph properties that enable discrimination between
the different states of brain tissue.
Application to Studying Temporal Activity of Adult Human
Mesenchymal Stems Cells in a 3-D Collagen Matrix: Fig. 9
shows relationships between adult human mesenchymal stem
cells in a 3-D collagen protein matrix over time in culture
[90]. The graphs are generated from 3-D sections of tissue
(900 900 800 ) imaged using confocal microscopy. The
nuclei of stem cells in the constructs were stained and imaged
at the time points indicated (0–24 h).
Application of Graph Theory to Modeling Cancer Grade:
In [92], the Voronoi diagram is constructed from a set of seed-
like points that denote the centers of each structure of interest
(nuclei). From the Voronoi diagram, two more graphs of interest
can be constructed: the Delaunay triangulation, which is created
by connecting points that share an edge in the Voronoi diagram,
and the minimum spanning tree, which is the series of lines that
spans the set of points such that the Euclidean sum of the lengths
of the lines is smaller than any other spanning tree. From each
of these three graphs, a series of features are calculated that
captures the size, shape, and arrangement of the structures of
the nuclei. The graph-based representations of a Gleason grade
4 prostate histopathology image are shown in Fig. 10.
Fig. 9. Cell graphs produced from human MSC embedded in 3-D collagen
matrices. Graphs show nuclei and development of edges (relationships) between
them over time [90]. There is a phase transition sometime between hour 10 and
hour 16 and the graph becomes connected.
C. Multiscale Feature Extraction
Owing to the density of the data and the fact that patholo-
gists tend to employ a multiresolution approach to analyzing
pathology data, feature values are related to the viewing scale
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Fig. 10. (a) A digitized histopathology image of Grade 4 CaP and different graph-based representations of tissue architecture via Delaunay Triangulation, Voronoi
Diagram, and Minimum Spanning tree.
Fig. 11. Digitized histological image at successively higher scales (magnifica-
tions) yields incrementally more discriminatory information in order to detect
suspicious regions.
or resolution. For instance at low or coarse scales color or tex-
ture cues are commonly used and at medium scales architec-
tural arrangement of individual histological structures (glands
and nuclei) start to become resolvable. It is only at higher res-
olutions that morphology of specific histological structures can
be discerned.
In [93], [94], a multiresolution approach has been used for the
classification of high-resolution whole-slide histopathology im-
ages. The proposed multiresolution approach mimics the eval-
uation of a pathologist such that image analysis starts from the
lowest resolution, which corresponds to the lower magnification
levels in a microscope and uses the higher resolution represen-
tations for the regions requiring more detailed information for
a classification decision. To achieve this, images were decom-
posed into multiresolution representations using the Gaussian
pyramid approach [95]. This is followed by color space con-
version and feature construction followed by feature extraction
and feature selection at each resolution level. Once the classifier
is confident enough at a particular resolution level, the system
assigns a classification label (e.g., stroma-rich, stroma-poor or
undifferentiated, poorly differentiating, differentiating) to the
image tile. The resulting classification map from all image tiles
forms the final classification map. The classification of a whole-
slide image is achieved by dividing into smaller image tiles and
processing each image tile independently in parallel on a cluster
of computer nodes.
As an example, refer to Fig. 11, showing a hierarchical
cascaded scheme for detecting suspicious areas on digitized
prostate histopathology slides as presented in [96].
Fig. 12 shows the results of a hierarchical classifier for detec-
tion of prostate cancer from digitized histopathology. Fig. 12(a)
Fig. 12. Results from the hierarchical machine learning classifier. (a) Original
image with the tumor region (ground truth) in black contour, (b) results at scale
1, (c) results at scale 2, and (d) results at scale 3. Note that only areas determined
as suspicious at lower scales are considered for further analysis at higher scales.
shows the original image with tumor outlined in black. The next
three columns show the classifier results at increasing analysis
scales. Pixels classified as “nontumor” at a lower magnification
(scale) are discarded at the subsequent higher scale, reducing
the number of pixels needed for analysis at higher scales. Ad-
ditionally, the presence of more discriminating information at
higher scales allows the classifier to better distinguish between
tumor and nontumor pixels.
At lower resolutions of histological imagery, textural analysis
is commonly used to capture tissue architecture, i.e., the overall
pattern of glands, stroma and organ organization. For each digi-
tized histological image several hundred corresponding feature
scenes can be generated. Texture feature values are assigned
to every pixel in the corresponding image. 3-D statistical, gra-
dient, and Gabor filters can be extracted in order to analyze
the scale, orientation, and anisotropic information of the re-
gion of interest. Filter operators are applied in order to extract
features within local neighborhoods centered at every spatial
location. At medium resolution, architectural arrangement of
nuclei within each cancer grade can be described via several
graph-based algorithms. At higher resolutions, nuclei and the
margin and boundary appearance of ductal and glandular struc-
tures have proved to be of discriminatory importance. Many of
these features are summarized in Tables I and II.
D. Feature Selection, Dimensionality Reduction,
and Manifold Learning
1) Feature Selection: While humans have innate abilities to
process and understand imagery, they do not tend to excel at
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explaining how they reach their decisions. As such, large fea-
ture sets are generated in the hopes that some subset of features
incorporates the information used by the human expert for anal-
ysis. Therefore, many of the generated features could be redun-
dant or irrelevant. Actually, a large set of features may possibly
be detrimental to the classification performance, a phenomenon
known as “the curse of dimensionality.” Feature selection is a
means to select the relevant and important features from a large
set of features. This is an increasingly important area of research
now that automated quantitative image analysis techniques are
becoming more mainstream.
Feature selection in histopathological image analysis pro-
vides several benefits in addition to improving accuracy. Since
images tend to be relatively large, a smaller subset of features
needs to be calculated, reducing the computational complexity
of classification algorithms. In some applications, it may be
preferable to sacrifice the overall performance slightly if this
sacrifice greatly reduces the number of selected features. A
smaller number of features would also make it easier to explain
the underlying model and improve the chances of generaliza-
tion of the developed system. Additionally, in a multiresolution
framework, a set of features proven useful at a given resolution
may not be relevant at another resolution, even within the same
image. A feature selection algorithm helps determine which
features should be used at a given resolution.
An optimal feature selection method would require an ex-
haustive search, which is not practical for a large set of features
generated from a large dataset. Therefore, several heuristic al-
gorithms have been developed, which use classification accu-
racy as the optimality criterion. Well-known feature selection
methods include the sequential search methods, namely sequen-
tial forward selection (SFS) and sequential backward selection
(SBS) [97]. SFS works by sequentially adding the feature that
most improves the classification performance; similarly, SBS
begins with the entire feature set and sequentially removes the
feature that most improves the classification performance. Both
SFS and SBS suffer from the “nesting effect” whereby features
that are selected (SFS) or discarded (SBS) cannot be revisited
in a later step and are thus sub-optimal [97]. The use of floating
search methods, sequential floating forward search (SFFS) and
sequential floating backward search (SFBS), in which previ-
ously selected or discarded features can be re-evaluated at later
steps avoids the nesting problem [97]. While these methods still
cannot guarantee optimality of the selected feature subset, they
have been shown to perform very well compared to other feature
selection methods [98] and are, furthermore, much more com-
putationally efficient [97]. SFFS is one of the most commonly
encountered feature selection methods in pathology image anal-
ysis literature.
More recent feature selection research has focused on such
methods as genetic algorithms, simulated annealing, boosting
[99] and grafting [100]. A taxonomy of feature selection
algorithms is presented in [98]. Genetic algorithms and sim-
ulated annealing are applications of traditional optimization
techniques to feature selection. Boosting, which will be ex-
plained in Section VI-C, basically acts as a greedy feature
selection process. Grafting (from “gradient feature testing”)
[100] is based on an elegant formulation of the feature selection
problem, whereby the classification of the underlying data
and the feature selection process are not separated. Within the
grafting framework, a loss function is used that shows prefer-
ence for classifiers that separate the data with larger margins.
Grafting also provides an efficient framework for selection of
relevant features. Feature selection based on a measure of dis-
criminatory power was proposed in [101], whereby the authors
compute the discriminatory power of each of the wavelet packet
sub-bands (features) using a dissimilarity measure between ap-
proximated probability density functions for different classes.
Derived features are then sorted according to the discriminatory
power values associated with the corresponding features.
2) Dimensionality Reduction: While feature selection aims
to select features (and reduce the feature dimensionality) that
best optimize some criterion related to the class labels of the
data (e.g., classification performance), dimensionality reduction
techniques aim to reduce dimensionality based on some other
criterion. Three well-known and commonly used methods of
linear dimensionality reduction are principal component anal-
ysis (PCA), independent component analysis (ICA), and linear
discriminant analysis (LDA).
Principal component analysis (PCA) [102] looks to find a new
orthogonal coordinate system whereby the maximum variance
of the data is incorporated in the first few dimensions. Projection
of the data onto the individual coordinates encompasses varying
degrees of variance; the first coordinate encompasses the largest
variance in the data, the second coordinate the next largest vari-
ance, and so forth.
On the other hand, the LDA is a supervised method; it thus re-
quires class labels for each data sample, mapping the data onto
a lower dimensional sub-space that best discriminates data. The
goal is to find the mapping, where the sum of distances between
samples in different classes is maximized; while the sum of dis-
tances between samples in same classes is minimized. LDA can
also be formulated in terms of eigenanalysis. A comprehensive
discussion of PCA and LDA can be found in [103].
Independent component analysis [104], looks to find some
mixing matrix such that a mixture of the observations (features)
are statistically independent. This provides a stronger constraint
on the resulting components than PCA, which only requires that
the components be uncorrelated. This is why it is particularly
well suited for decorrelating independent components from hy-
perspectral data. Rajpoot and Rajpoot have shown ICA to per-
form well for extracting three independent components corre-
sponding to three tissue types for segmentation of hyperspectral
images of colon histology samples. ICA, however, provides no
ranking of the resulting independent components, as does PCA.
There are a variety of methods for calculating the independent
components (refer to [104]), which are generally very computa-
tionally intensive. ICA is a higher order method that seeks linear
projections, not necessarily orthogonal to each other, as in the
case of PCA.
3) Manifold Learning: Recently, nonlinear dimensionality
reduction methods have become popular in learning applica-
tions. These methods overcome a major limitation of linear di-
mensionality reduction methods, which assume that geomet-
rical structure of the high-dimensional feature space is linear.
In reality, high-dimensional feature spaces comprise of highly
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Fig. 13. Low-dimensional embedding reveals innate structure in textural features of invasive breast cancers, with clear separation of high grade tumors from low
and intermediate grade tumors as assessed by Nottingham score. Combined Nottingham score 5 (yellow triangle), 6 (green squares), 7 (blue circles), and 8 (red
triangles). The score of 8 corresponds to high grade tumors. (a) Low grade (Yellow triangles). (b) High grade (Red triangles).
nonlinear structures and locality preserving dimensionality re-
duction methods are highly sought after. Manifold learning is a
method of reducing a data set from to dimensions, where
while preserving inter- and intra-class relationships
between the data. This is done by projecting the data into a
low-dimensional feature space in such a way to preserve high
dimensional object adjacency. Many manifold learning algo-
rithms have been constructed over the years to deal with dif-
ferent types of data.
Graph embedding constructs a confusion matrix describing
the similarity between any two images and with feature
vectors and , respectively, where
and is the total number of images in the data set
(5.1)
The embedding vector is obtained from the maximization of
the function
(5.2)
where is the so-called degree matrix, with nonzero values
being along the diagonal and .
The dimensional embedding space is defined by the eigen-
vectors corresponding to the smallest eigenvalues of
. The value of is generally optimized by ob-
taining classification accuracies for and se-
lecting the that provided the highest accuracy for each clas-
sification task. For image , the feature vector given as input
to the graph embedding algorithm produces an -dimensional
eigenvector , where
is the principal eigenvalue associated with .
In [92], a graph embedding algorithm employing the normal-
ized cuts algorithm was used to reconstruct the underlying man-
ifold on which different breast cancer grades were distributed.
Fig. 13 shows the embedding of different grades of breast cancer
histopathology (low, intermediate, high) on the reconstructed
manifold; low grades (yellow triangles), intermediate grades
(green squares and blue circles), and high grades (red triangles).
The manifold captures the biological transformation of the dis-
ease in its transition from low to high-grade cancer.
Manifold learning has also been shown to be useful for shape-
based classification of prostate nuclei [105]. Rajpoot et al. [105]
employ diffusion maps [106] in order to reduce the dimension-
ality of shape descriptors down to two dimensions and a fast
classification algorithm is derived based on a simple thresh-
olding of the diffusion coordinates.
VI. CLASSIFICATION AND SUB-CELLULAR QUANTIFICATION
For histopathology imagery, unlike some other applications
of image analysis, one of the primary considerations in the
choice of a classifier is its ability to deal with large, highly dense
datasets. Also due to multiple image scales at which relevant
information may be extracted from histological imagery, use of
an ensemble of classifiers as opposed to a single classifier has
been proposed.
A. Multiclassifier Ensemble Schemes
Theoretical and empirical results alike have established that,
in terms of accuracy, ensembles of classifiers generally outper-
form monolithic solutions. Learning ensembles or multiple clas-
sifier systems are methods for improving classification accuracy
through aggregation of several similar classifiers’ predictions
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TABLE III
THE AVERAGE ACCURACY RESULTS OF THE DISEASED-HEALTHY-DAMAGED CLASSIFICATION ON THE TEST SET BY USING FIVE DIFFERENT APPROACHES.
and thereby reducing either the bias or variance of the individual
classifiers [107].
1) A Support Vector Machines (SVM): SVMs project a set of
training data representing two different classes into a high-
dimensional space by means of a kernel function . The al-
gorithm then generates a discriminating hyper-plane to sepa-
rate out the classes in such a way to maximize a cost function.
Testing data is then projected into the high-dimensional space
via , and the test data is classified based on where it falls
with respect to the hyper-plane. The kernel function de-
fines the method in which data is projected into the high-dimen-
sional space. A commonly used kernel known as the radial basis
function has been employed to distinguish between three dif-
ferent prostate tissue classes [108]. Radial basis functions with
a grid search for their parameters have also been used to differ-
entiate colon adenocarcinoma histopathology images from be-
nign histopathology images [109] and to classify four different
subtypes of meningioma [101].
2) Adaboost: The AdaBoost is an adaptive algorithm in
the sense it combines a number of weak classifiers to generate
a strong classifier. Image pixels determined as diseased by
a pathologist during the training stage are used to generate
probability density functions (pdfs) for each of the individual
texture features , for which are consid-
ered as weak classifiers [110]. Bayes Theorem is then used
to generate likelihood scenes
for each which constitute the weak learners. These are
combined by the AdaBoost algorithm into a strong classifier
where for every pixel , is the
combined likelihood that pixel belongs to cancer class ,
is the weight determined during training for feature , and
is the number of iterations.
In [110] a hierarchical boosted cascade scheme for detecting
suspicious areas on digitized prostate histopathology, inspired
by the work of Viola and Jones [111] was presented. Efficient
and accurate analysis is performed by first only detecting those
areas that are found to be suspicious at lower scales. Analysis
at subsequent higher magnifications is limited to those regions
deemed to be suspicious at lower scales. Pixels classified as
“nontumor” at a lower magnification (scale) are discarded at the
subsequent higher scale, reducing the number of pixels needed
for analysis at higher scales. The process is repeated using an
increasingly larger number of image features and an increasing
classification threshold at each iteration. Qualitative results with
a hierarchical Boosted classifier at three different image resolu-
tions are shown in Fig. 14.
Fig. 14. From left to right, (a) A digitized histopathology image, (b) cancer ex-
tent delineated in black by an expert pathologist, and cancer probability images
generated by an Adaboost classifier at (c) low-, (d) intermediate, and (e) high
image resolutions.
B. Disease Discrimination Based on Graph-Based Features
Table III shows the average accuracy and corresponding
standard deviation over 20 runs of randomized cross validation
based classification of the diseased-healthy-damaged studies
by using five different approaches: 1) the cell graph approach;
2) the cell-distribution approach in which features are extracted
from the spatial distribution of cells without considering their
pair-wise spatial relations (i.e., without considering the edge
information); 3) the textural approach in which features are
derived from the gray-level interdependency of pixels in a
tissue image; 4) the intensity-based approach in which features
are derived from the intensity values of pixels in a tissue image;
and 5) the Voronoi diagram-based approach in which features
are extracted by making use of the spatial interrelationships of
adjacent cells [112], [113].
C. Grade-Based Classification of Histopathology Imagery
The classification of histopathology imagery is often the
ultimate goal in image analysis, particularly in cancer appli-
cations. Features derived from segmented nuclei and glands
from histopathology are usually a prerequisite to extracting
higher level information regarding the state of the disease. For
instance, the grading of prostate cancer by Jafari-Khouzani and
Soltanian-Zadeh [114] yielded 97% accuracy for H&E stained
imagery based on features derived from nuclear structures in
histopathology. Weyn et al. [115] reported 87.1%–96.8% accu-
racy in the correct diagnosis (3 diagnoses) of Feulgen-stained
lung cancer specimens, 79.5%–92.3% accuracy in typing (3
types) malignant mesothelioma, and 74.3%–82.9% accuracy
in the prognosis (3 classes of survival time) of malignant
mesothelioma cases. Analysis of Feulgen-stained breast tissue
sections by van de Wouwer et al. [116] found 67.1% accuracy
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Fig. 15. (a) (left panel) Low dimensional representation (via nonlinear dimensionality reduction) of prostate cancer histopathology images (green circles are Grade
3 images and blue squares represent Grade 4 prostate cancer images). A nonlinear SVM is used to classify objects in the reduced dimensional space. (b) Right
panel shows a classification accuracy of over 90% in distinguishing between Grade 3, Grade 4 images and comparable accuracy in distinguishing between benign
stromal, epithelial, and prostate cancer tissue.
in clasifying nuclei as benign or malignant, but 100% clas-
sification on a patient level. Tabesh et al. [117] found 96.7%
accuracy in discriminating between prostate tissue slides with
cancer and no cancer, and 81% accuracy in the discrimination
between low and high Gleason grades in the same imagery.
Immunohistochemically stained colon mucosa allowed for an
accuracy of 92% in classification of benign and malignant
images by Esgiar et al. [118].
The classification of histopathology imagery using spatial ar-
chitecture information as presented in Weyn et al. [115] re-
sulted in 88.7%–96.8% accuracy in the diagnosis of lung cancer,
94.9% accuracy in the typing of malignant mesothelioma, and
80.0%–82.9% accuracy in the prognosis of malignant mesothe-
lioma for Feulgen-stained lung sections. The analysis of H&E
stained brain tissue by Demir et al. [112] gave 95.5%–97.1%
accuracy in the discrimination between benign and cancerous
tissue. Keenan et al. [119] reported accuracies of 62.3%–76.5%
in the grading of H&E stained cervical tissue.
Fig. 15(a) shows the low dimensional embedding of the high
dimensional attribute space via locally linear embedding of 20
images representing prostate cancer grades 3 (green circles)
and 4 (blue squares). Each image is displayed as a point in 3D
eigenspace. The clustering clearly shows very good discrim-
ination between these 2 classes which clinically is the most
challenging problem in terms of Gleason grading. Fig. 15(b)
shows bar plots reflecting the classification accuracy obtained
via a supervised classifier in distinguishing between pairs of
tissue classes – grade 3\4, grade 3 vs. benign epithelium, and
grade 4 vs. benign epithelium via a SVM classifier. Note that
in every case the classification accuracy is over 90%.
D. Sub-Cellular Quantification
Quantifying expression levels of proteins with sub-cel-
lular resolution is critical to many applications ranging from
biomarker discovery, pharmaceutical research, and systems
biology to treatment planning. In this section, a fully automated
method to quantify the expression levels of target proteins in
immunofluorescently stained samples in tissue micro arrays
(TMAs) is presented. Kolmogorov-Smirnov (KS) statistics, a
well-known method in statistics to test if two distributions are
different from each other, can be used to compute the relative
expression levels in each of the epithelial and nonepithelial
tissue regions. After the sub-cellular compartments are deter-
mined using membrane and nuclear markers, the distribution
of target proteins in each of these compartments are calcu-
lated. The estimated distribution comprises target distribution
from the expressed regions as well as nonspecific background
binding and tissue autofluorescence that may have left out
after the AF removal step. A signed KS distance (sKS) can be
defined as the product of the standard KS distance and a sign
function ( ) to indicate which compartment is expressed. For
example if sign function is computed between the nuclear and
the membrane expression levels, a negative sKS distance will
indicate a nuclear expression, and a positive sign will indicate
membrane expression. While the magnitude of the sKS distance
indicates how strong the expression level difference is between
these compartments, its sign indicates in which compartment
the protein is expressed.
The standard KS distance is defined as the maximum sepa-
ration between the cumulative distribution functions (CDF) of
two data sets. The CDF of a target protein in any compartment
can be calculated by integrating its intensity distribution esti-
mated using a Parzen window approach with Gaussian kernels.
Fig. 16(c) shows the CDF of the target distributions shown in
Fig. 16(a) (green color), on each of the segmented sub-cellular
regions; nuclei (blue), membrane (red), and cytoplasm (green)
shown in Fig. 16(b). The CDFs clearly indicate the overexpres-
sion of the nuclear region (blue plot) where approximately 10%
of the nuclear pixels express intensity values more than 50, as
opposed to a very small percentage for other compartments. The
sign of the sKS is determined based on sign of the difference
between the CDF of the first compartment and the CDF of the
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Fig. 16. (a) A histological section stained with nuclear (DAPI-Blue), mem-
brane (Pan-cadherin, red), and a target protein (Estrogen Receptor (ER), green).
(b) Automatically segmented sub-cellular regions; membrane (red), nuclei
(blue), cytoplasm (green). Dark colors show the nonepithelial regions. (c) CDF
of the ER distributions (nuclei in blue, membrane in red and cytoplasm in green
plots).
second compartment at the protein expression level with highest
CDF separation.
The sKS metric on 123 TMA images from 55 patients (some
patients are represented as multiple tissue cores) stained with
DAPI (nuclei), pan-cadherin (membrane), keratin (tumor/ep-
ithelial mask), and ER markers were tested. DAPI and pan-cad-
herin are used to segment the sub-cellular compartments, and
keratin to segment the epithelial mask. Then the distribution of
the ER protein is calculated on each of the epithelial sub-cellular
regions. ER is expected to partially or fully express in the nu-
clear region for ER positive patients. A target distribution is usu-
ally observed mixed with nonspecific expression and auto-fluo-
rescence (AF). The sKS based metric was compared to the ma-
jority decision of a group of 19 observers scoring estrogen re-
ceptor (ER) status, and achieved 96% detection rate with 90%
specificity. The presented methods have applications from diag-
nostics to biomarker discovery and pharmaceutical research.
VII. LOOKING AHEAD: FUTURE TRENDS, OPEN PROBLEMS
Since histopathological image analysis is inherently a cross-
disciplinary area, there are unique challenges to the dissemi-
nation of research results. One of these is the wide range of
publications in which research is published. While there are a
few journals that focus on the automated analysis of medical
imagery, the majority of histopathological image analysis tends
to be published in the leading journals of the researchers’ field
(pathology, computer vision, etc.). Additionally, there is a need
for more evidence regarding the clinical applicability and im-
portance of automated histopathology image analysis methods.
We have mentioned areas throughout this paper for which we
anticipate ongoing research to have a clear and tangible affect
on clinical and pathology workflow.
Comparison of the various methods presented in the literature
is difficult, since each research team uses their own dataset and
presents their results with different metrics. There is a great need
for standard datasets and ground truth for validation of methods.
As an example, researchers at the University of South Florida
have put together a database of digital mammograms.1 While the
variety of conditions studied in histopathology image analysis
is greater, it is still important that standard datasets be compiled
as well as a standard metric of performance. This will allow for
direct comparison of the variety of analysis methods being re-
ported in the literature. An additional complication is the variety
of analyses performed on the histopathology imagery. Thus,
there is a need for a dataset with ground truth pertaining to all
the analyses described in this paper.
Going forward, clinical annotation of histopathology data
will be a large bottleneck in the evaluation of histopathology
related CAD algorithms. Apart from the time constraints on
the pathologist to generate this data, the process should be
streamlined with active communication between the image
analysis scientists and the clinicians with regard to the sort of
annotation required, the format and scale at which the annota-
tion is generated, and the ease with which the data can be shared
(since histopathology files typically tend to be very large). For
instance, the sophistication of annotation required to train a
CAD system to distinguish cancerous versus noncancerous
regions on pathology images may be very different than the
annotation detail required to train a classifier to distinguish
grades of cancer. While for the former problem the annotation
could be done on a coarser scale (lower resolution), the latter
annotation may require explicit segmentation of glands and
nuclei, a far more laborious and time consuming process.
Due to the large size of pathological images, usually it is not
possible to process the whole image on a single-core processor.
Therefore, the whole image may be divided into tiles and each
tile is processed independently. As a consequence, automatic
load balancing in the distribution of the cases to different
processors need to be handled carefully [120]. Additionally,
the processing can be accelerated even further by the use of
graphical processing units (GPUs), cell blades, or any other
emerging high-performance architecture [121].
Histopathological image analysis system evaluation needs to
be carried out in a statistical framework. Depending on whether
it is a problem of detection (e.g., nuclei detection) or charac-
terization (e.g., grading), some commonly accepted evaluation
methodologies need to be followed. Some of these methods,
e.g., receiver operating characteristics (ROC) and free response
operating characteristics (FROC), have been successfully used
for many years in radiology [122]. These techniques could be
adopted or adapted accordingly. The level and detailed of quan-
titative evaluation will vary as a function of the specific problem
being addressed. For instance, in order to evaluate a nuclear
segmentation algorithm on a digitized histological section con-
taining several tens of thousands of nuclei, it is unreasonable to
1http://marathon.csee.usf.edu/Mammography/Database.html
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Fig. 17. (a) Histology section of prostate gland with CaP extent stained in
purple (upper right) and corresponding mapping of CaP extent via COFEMI
onto (b) MRI (CaP extent shown in green). (c) Overlay of histological and MRI
prostate sections following registration.
expect that a human reader will be able to manually annotate
all nuclei. Evaluation of the scheme may have to be performed
on randomly chosen segments of the image. Similarly, if the ul-
timate objective of the CAD algorithm is, for instance, cancer
grading, perfect segmentation of histological structures may not
guarantee perfect grade-based classification. Evaluation should
hence be tailored towards the ultimate objective that the CAD
algorithm is being employed for. Additionally, special attention
needs to be paid to clearly separate training and testing datasets
and explain the evaluation methodology.
A. Multimodal Data Fusion/Registration
While digital pathology offers very interesting, highly dense
data, one of the exciting challenges will be in the area of mul-
timodal data fusion. One of the big open questions, especially
as it pertains to personalized medicine, will be the use of multi-
modal data classifiers to be able to make therapy recommenda-
tions. This will require solving questions both in terms of data
alignment and in terms of knowledge representation for fusion
of heterogeneous sources of data, in order to answer questions
that go beyond just diagnosis, such as theragnosis (therapy pre-
diction) and prognosis.
H&E staining is traditionally used for histopathology
imaging. Several other modalities exist for imaging of the
tissue, each offering its own advantages and limitations. Com-
bining images from different modalities, therefore, may seem
to be an attractive proposition, although it does not come
without its own challenges, most importantly registration, not
to mention the extra cost associated with imaging, storage,
and computational time. Registration of image data across
the different modalities and fusion of the information con-
tained therein result in a powerful resource of information
for diagnosis and prognosis purposes. Fusion methods have
been developed for images from different microscopy imaging
methods [26] and micro-scale histopathology and large-scale
MR images [123]–[125].
Madabhushi et al. [126] have been developing computerized
detection methods for prostate cancer from high-resolution mul-
timodal MRI . A prerequisite to training a supervised classi-
fier to identify prostate cancer (CaP) on MRI is the ability to
precisely determine spatial extent of CaP on the radiological
imaging modality. CaP can be precisely determined on whole
mount histopathology specimens [Fig. 17(a)] which can then
be mapped onto MRI [Fig. 17(b)]. Fig. 17(c) shows the result
of registering [Fig. 17(b)] the 2-D MRI slice to the histological
section [Fig. 17(a)]. This requires the use of sophisticated and
robust multimodal deformable registration methods to account
for (a) deformations and tissue loss in the whole mount histo-
logical specimens during acquisition, and (b) ability to over-
come intensity and feature differences between the two modal-
ities (histopathology and MRI). In [123], [124] a rigid registra-
tion scheme called combined feature ensemble based mutual in-
formation (COFEMI) was presented that used alternate feature
representations of the target and source images to be registered
to facilitate the alignment.
B. Correlating Histological Signatures With Protein
and Gene Expression
Multiplexing, imaging of a tissue sample with several an-
tibodies simultaneously, allows correlation of characteristic
patterns in histopathology images to expression of proteins.
Teverovskiy et al. [127] recently proposed a novel scheme for
automated localization and quantification of the expression of
protein biomarkers using a DAPI counter-stain and three other
biomarkers. They showed it to be useful for predicting recur-
rence of prostate cancer in patients undergoing prostatectomy.
Recently, it has become clear that information regarding ex-
pression of certain proteins related to the onset of cancer is not
sufficient. Analyzing multiple-stained histopathology images
can help identify oncogenesis-induced changes in sub-cellular
location patterns of proteins. Glory et al. [128] proposed a
novel approach to compare the sub-cellular location of proteins
between normal and cancerous tissues. Such a method can also
be used for identification of proteins to be used as potential
biomarkers.
C. Exploratory Histopathology Image Analysis
Exploratory analysis of histopathology images can help in
finding salient diagnostic features used by humans, associating
them with the computed features, and visualizing relationships
between different features in high-dimensional spaces. Less-
mann et al. [129] have proposed the use of self-organizing maps
(SOMs) for exploratory analysis of their wavelet-based feature
space. The SOM-based visualization of the feature space al-
lowed the authors of [129] to establish a correlation between
single features and histologically relevant image structures,
making the selection of a subset of clinically important features
possible. Iglesias-Rozas and Hopf [130] showed that SOMs can
be effectively employed to correctly classify different subtypes
of human Glioblastomas (GB) and also to select significant
histological and clinical or genetic variables. Alternatively,
dimensionality reduction methods may offer a way of looking
at trends and patterns in the data in a reduced dimensional
space [131]–[133].
D. Computer-Aided Prognosis
The use of computer-aided diagnosis for digitized
histopathology could begin to be employed for disease prog-
nostics, allowing physicians to predict which patients may be
susceptible to a particular disease and also predicting disease
outcome and survival. For instance, since grade is known to
be correlated to outcome (high grade correlates to worse out-
come), image-based predictors could be used to predict disease
recurrence and survival based on analysis of biopsy specimens
alone. This would have significant translational implications in
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that; more expensive molecular assays may not be required for
predicting disease.
While there may be a small minority of researchers who are
experts in both computer vision and pathology, the vast majority
of histopathology image analysis researchers are computer vi-
sion researchers. As such, it is important to maintain a constant
collaboration with clinical and research pathologists throughout
the research process. There are unique challenges to analysis of
medical imagery, particularly in the performances required for
eventual use of the technique in a clinical setting. It is the pathol-
ogist who can best provide the feedback on the performance of
the system, as well as suggesting new avenues of research that
would provide beneficial information to the pathologist com-
munity. Additionally, it is the pathologist that is best equipped
to interpret the analysis results in light of underlying biolog-
ical mechanisms which, in turn, may lead to new research ideas.
Similarly, where appropriate it might be pertinent to include the
oncologist and radiologist within the algorithmic development
and evaluation loop as well.
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